+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Helping patients with prostate cancer



Helping patients with prostate cancer



Urologic Nursing 11(2): 4




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040260011

Download citation: RISBibTeXText

PMID: 2057785


Related references

What's a doctor to do? Helping patients decide about prostate cancer screening. Canadian Family Physician Medecin de Famille Canadien 50: 14-6 22-4, 2004

Helping patients with localized prostate cancer reach treatment decisions. Canadian Family Physician Medecin de Famille Canadien 56(2): 137-141, 2010

Supporting the supporter: helping the partner of patients newly diagnosed with prostate cancer. Bju International 105(11): 1489-1490, 2010

Metastatic castration-resistant prostate cancer. Part 2: helping patients make informed choices and managing treatment side effects. European Journal of Oncology Nursing 17(Suppl. 1): S7, 2013

Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7. European Urology 70(4): 684-691, 2016

Prostate cancer in patients with screening serum prostate specific antigen values less than 4.0 ng/dl: results from the cooperative prostate cancer tissue resource. Journal of Urology 173(5): 1546-1551, 2005

Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer. International Journal of Radiation Oncology Biology Physics 53(3): 581-587, 2002

Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients. Oncology Reports 12(3): 601-607, 2004

Observations of the doubling time of prostate cancer as measured by serial prostate specific antigen in untreated patients with prostate cancer. Journal of Urology 147(4 Suppl.): 387A, 1992

Prostate-specific antigen and prognosis in patients with metastatic prostate cancer: A multivariable analysis of prostate cancer mortality. British Journal of Urology 75(4): 507-515, 1995

OncoVax-PTM vaccine for prostate cancer induces immune responses to prostate specific antigen in prostate cancer patients. Proceedings of the American Association for Cancer Research Annual Meeting 40: 576-577, 1999

Serum early prostate cancer antigen (EPCA) as a significant predictor of incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia. Prostate 70(16): 1788-1798, 2010

Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients. Prostate 75(12): 1312-1321, 2015

A population-based study of cancer incidence in relatives of prostate cancer patients in Finland High risk of late-onset prostate cancer and association with stomach cancer. American Journal of Human Genetics 65(4): A40, 1999